Beta Bionics (BBNX) Free Cash Flow (2024 - 2026)

Beta Bionics has disclosed Free Cash Flow across 3 years of filings, most recently posting -$15.7 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 1.87% year-over-year to -$15.7 million; the TTM figure through Jun 2026 stood at -$61.4 million (up 0.97% YoY), while the FY2025 annual figure was -$56.2 million, down 8.81% from the prior year.
• Free Cash Flow came in at -$15.7 million for Q2 2026 at Beta Bionics, up from -$25.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$10.0 million in Q3 2025 to a low of -$25.2 million in Q1 2026.
• Average Free Cash Flow over 3 years is -$14.9 million, with a median of -$13.8 million recorded in 2024.
• The largest YoY upside for Free Cash Flow was 29.04% in 2025 against a maximum downside of 61.82% in 2025.
• Over 3 years, Free Cash Flow stood at -$14.8 million in 2024, then advanced by 29.04% to -$10.5 million in 2025, then plunged by 48.73% to -$15.7 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$15.7 million in Q2 2026, -$25.2 million in Q1 2026, and -$10.5 million in Q4 2025.